| Errores en prescripción y transcripción de medicamentos endovenosos en cuatro servicios pediátricos |
Frequency of prescription and transcription errors for intravenous medications in four pediatric services.
Rivas E, Rivas A, Bustos L.
Departamentos de Pediatría y Cirugía Infantil, Facultad de Medicina, Universidad de La Frontera, Temuco, Chile. erivas@ufro.cl
Rev Med Chil. 2010 Dec;138(12):1524-9. Epub 2011 Feb 7.
Abstract
BACKGROUND: Errors in the prescription and transcription of medications in pediatric services is a source of adverse events that can be prevented. AIM: To determine and compare the frequency of prescription and transcription errors for intravenous drugs in four pediatric services in a regional general hospital. MATERIAL AND METHODS: Cross sectional analysis of a probabilistic sample of 500 prescriptions of intravenous medications. Information was gathered using an instrument from the American Academy of Pediatrics. RESULTS: The detected prescription errors were illegible indications in 20%, lack of dosing indication in 11%, omission of the administration route in 24% and omission of the frequency of administration in 15%. Transcription errors were illegible transcription in 3%, not transcribing all indicated medications in 4% and transcription of medications that were not prescribed in 3%. Twenty one percent of prescriptions and 6% of transcriptions had at least one incorrect action. In the different services studied there was a significant association between the percentage of incorrect prescriptions and transcriptions and between illegible prescriptions and transcriptions. CONCLUSIONS: A high percentage of errors in prescription of intravenous medications and their transcriptions, was detected in these services. A better quality of care control is requiredhttp://www.scielo.cl/pdf/rmc/v138n12/art08.pdf
|
| Una historia de muchas potencias: ¿Podremos minimizar errores de prescripción y administración con tantas formulaciones en el mercado? |
A tale of too many strengths: Can we minimize prescribing errors and dispensing errors with so many formulations in the market?
Gitanjali B.
J Pharmacol Pharmacother 2011;2:147-9
There are reportedly more than 1,00,000 drug formulations in the market in India. I have not seen a complete list of all the formulations nor been able to verify this figure which has remained unchanged since my days as a postgraduate (which was a very long time ago). However, anyone who has had the patience to look at the branded formulations in any one of the indexing drug formularies will be convinced that this figure could be correct. One of the recent issues of Indian Drug Review (IDR) had approximately 1980 medicines listed under the alphabet 'A'. Some other alphabets had much longer lists. So what is wrong with a country having such a large number of medicines, in different dosage formulations of varying strengths?
The case report described in page "189" is one such example of the many dangers of having too many choices. Paracetamol is one of the most commonly used analgesic and antipyretic in children. The oral liquid formulation is used mainly in small children. Leaving aside the fact that the parents could not read the label as it was in Spanish and presumed the strength to be similar to what is commonly prescribed used in the United Kingdom, why should there be a formulation with a dosage strength of 500 mg/5 ml? Any child requiring this dose (500 mg) should, in the normal course of events, be able to swallow a tablet of the same strength. There may be a small group of elderly patients who are not able to swallow tablets who will perhaps need this formulation. But this group will be extremely small, so small that it would not be financially beneficial for these companies to produce this strength solely for this small group of potential users. However, the potential for harm, as illustrated in this report, is much bigger.http://www.jpharmacol.com/temp/JPharmacolPharmacother23147-4554877_123908.pdf
|
|
No hay comentarios:
Publicar un comentario